The Industrial Design Office has announced that it is changing its practice with respect to industrial designs applied to buildings or structures.
Under the previous policy, designs applied to buildings or structures to be constructed on-site were not registrable because they were not considered to be “finished articles” to which a design may be applied. They were only registrable if the designs were capable of being “preformed, portable and delivered to purchasers as finished articles or in sections to be put together by a simple operation such as bolting”.
As of June 14, 2024, the Office will take the position that buildings and structures, including those constructed on-site, may be acceptable finished articles to which a design can be applied. The revised practice is applicable to all pending applications, regardless of their filing date.
The new policy is stated in section 13.02.03.04 of the Industrial Design Office Practice Manual.
This is a welcome development and the Office’s communication recognizes that “Broadening the scope of acceptable industrial design subject matter to include buildings and structures constructed on-site fosters and supports innovation and creativity by encouraging innovators in that industry to continue developing new designs for buildings and structures knowing that industrial design protection may be available.”
The change also aligns Canada with other jurisdictions, notably the United States, in which design patents are available for buildings and structures on-site. For example, Apple Inc. has obtained several patents for its building designs, including the cube design of its flagship store on Fifth Avenue in New York and its two-level store design in Joy City mall in China.
For more information, please contact a member of our Industrial Design practice group.
Related Publications & Articles
-
Trends in patent filing for artificial intelligence-assisted medical technologies
Medical technologies incorporating artificial intelligence (AI) are an emerging area of innovation with the potential to transform healthcare. Employing techniques such as machine learning, deep learn...Read More -
Federal Court of Appeal sets aside two-stage test for assessing “due care”
On September 5, 2025, the Federal Court of Appeal (FCA) set aside the decision of the Federal Court (FC) in Matco Tools Corporation v Canada (Attorney General), 2025 FC 118, and restored a decision of...Read More -
Supreme Court of Canada reserves decision on appeal relating to the patentability of methods of medical treatment
Today, the Supreme Court heard oral arguments in Pharmascience Inc v Janssen Inc (Supreme Court File No 41209) and reserved its decision.Read More